OVERVIEW

Sexual health has been identified as a growing priority in improving patient care. In 2005, the World Health Organization recommended that "providers should receive training in human sexuality, to help them better address the sexual health needs of their clients." Despite this impetus, recent data show that only 3% of physicians actually ask about sexuality in their patients. Several medical associations have identified the improvement of physician communication skills as an educational priority, as many clinicians feel they have received improper training in this area. Meanwhile, data show that routine evaluation of sexual health has the potential to decrease morbidity and mortality, and enhance the well-being and longevity of patients' lives.

This program will give health care providers an enhanced understanding of the value of sexual health on patients' outcomes and quality of life.

• Clinicians will learn through real-world examples ways to explore and lead a conversation about sexual function.
• Clinical scenarios and a video vignette will help clinicians reflect on and adapt an appropriate and respectful approach to their female patients.
• Dr. Sarrel will discuss ways to engage and control the dialogue about sexual function.
• Dr. Clayton will explain the importance of evaluating sexual well-being as part of an overall patient evaluation.
• The faculty will present several tools to obtain clinically meaningful information.

Clinicians will discover that a thorough understanding of patients' sexual histories, combined with appropriate management and counseling strategies, will ultimately contribute to an increase in positive clinical outcomes.

Faculty

	James A. Simon, MD (Chair) (read bio) Clinical Professor of Obstetrics and Gynecology George Washington University School of Medicine Washington, DC
	Philip M. Sarrel, MD (read bio) Emeritus Professor of Obstetrics, Gynecology, & Psychiatry Yale University School of Medicine Director, Yale Sex Counseling Program New Haven, CT
	Anita H. Clayton, MD (read bio) David C. Wilson, Professor, Vice Chair Department of Psychiatric Medicine Department of Psychiatry and Neurobehavioral Sciences University of Virginia Health System Charlottesville, VA

TARGET AUDIENCE

OB/GYNs, primary care physicians, and other heath care professionals who treat patients at risk for female sexual disorders.

EDUCATIONAL OBJECTIVES

This activity was designed to address the following IOM competencies: provide patient-centered care, and employ evidence-based practice.

At the conclusion of this activity, participants should be able to:

1. Explain and discuss the impact of sexual health dysfunction on patient outcomes

2. Demonstrate improved ability to:
   • Initiate and control dialogue about sexual health with their patients
   • Integrate questions or questionnaires about sexuality as part of routine patient evaluation

ACCREDITATION

The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION

The Potomac Center for Medical Education designates this educational activity for a maximum of 1.25 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

DISCLOSURE INFORMATION

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program sponsored by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. Disclosures will be made known to the participants prior to the activity.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

The faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

James A. Simon, MD: Consultant/Advisory Boards: Allergen; Alliance for Better Bone Health; Amgen Inc.; Ascend Therapeutics; Barr; Bayer; BioSante; Boehringer Ingelheim; Concert Pharmaceuticals; Concept Therapeutics Inc.; Depomed, Inc.; GlaxoSmithKline; KV Pharmaceutical; Meditrina Pharmaceuticals; Merck; Merrior Pharmaceuticals; Nanma/Tripharnma/Trinity; NDA Partners, Inc.; Novo Nordisk; Novogyne; Pear Tree Pharmaceuticals; QuatRx Pharmaceuticals; Roche; Schering-Plough; Sciele; Solvay; Ther-Rx; Warner Chilcott; Wyeth. Grants/Research Support: BioSante; Boehringer Ingelheim; FemmePharma; GlaxoSmithKline; Nanma/Tripharnma/Trinity; Novartis; Procter and Gamble. Speaker's Bureau: Amgen; Ascend; Barr; Bayer; Boehringer Ingelheim; GlaxoSmithKline; KV; Merck; Novartis; Novogyne; Sciele; Ther-Rx; Warner Chilcott; Wyeth.

Philip Sarrel, MD: Speaker: Barr/Teva Pharmaceuticals; Nouven Pharmaceuticals. Advisory Committee: Barr/Teva Pharmaceuticals; Nouven Pharmaceuticals. Honorarium: Barr/Teva Pharmaceuticals; Nouven Pharmaceuticals.

Anita Clayton, MD: Consulting, Speaker and Investigator: BioSante Pharmaceuticals, Inc.; Boehringer Ingelheim; Bristol-Myers Squibb; Eli Lilly and Co.; PGxHealth; Sanofi-Aventis; Takeda Global Research & Development; Trans Tech Pharma; Wyeth.

Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Carole Drexel, PhD; Kathy Merlo; Blair St. Amand: Nothing to Disclose.

FDA Disclosure

The contents of some CME/CE activities may contain discussions of non-approved or off label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

SYSTEM REQUIREMENTS

In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an Adobe Flash Player. The Adobe Flash Player can be downloaded here.

Sponsored by

This program is supported through an educational grant from Boehringer Ingelheim

By clicking this button you are agreeing that you have read and understood the CME Statements above.

Please view ALL presentations to receive your certificate.
Certificate access is located on the final slide in the final presentation.